Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes

• Published in: American journal of nephrology Vol. 45; no. 5; p. 431
• Main Authors: Bhandari, Simran K, Liu, In-Lu A, Kujubu, Dean A, Huynh, Trung, Behayaa, Hind, Kovesdy, Csaba P, Kalantar-Zadeh, Kamyar, Jacobsen, Steven J, Sim, John J
• Format: Journal Article
• Language: English
• Published: Switzerland 01.05.2017
• Subjects: Aged; Chelating Agents - therapeutic use; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia - blood; Hyperphosphatemia - drug therapy; Hyperphosphatemia - etiology; Hyperphosphatemia - mortality; Male; Middle Aged; Phosphates - blood; Renal Insufficiency, Chronic - blood; Renal Insufficiency, Chronic - complications; Renal Insufficiency, Chronic - drug therapy; Renal Insufficiency, Chronic - mortality; Retrospective Studies; Treatment Outcome; Phosphorus binders; Chronic kidney disease-mineral bone disorders; Epidemiology; Outcomes

Whether the benefits of phosphorus binders extend to those without end stage renal disease is uncertain. Among a large diverse non-dialysis chronic kidney disease (CKD) population with hyperphosphatemia, we sought to evaluate phosphorus binder use and compare mortality risk between patients prescrib...